Multimodality therapy of stage III adenocarcinoma of the breast
作者:
J. D. Bitran,
R. K. Desser,
D. Schifeling,
C. M. Shapiro,
M. F. Kozloff,
E. Robin,
W. Recant,
A. Michel,
H. Rochman,
A. A. Billings,
期刊:
Journal of Surgical Oncology
(WILEY Available online 1983)
卷期:
Volume 22,
issue 1
页码: 5-8
ISSN:0022-4790
年代: 1983
DOI:10.1002/jso.2930220103
出版商: Wiley Subscription Services, Inc., A Wiley Company
关键词: adenocarcinoma;breast cancer;multimodality therapy
数据来源: WILEY
摘要:
AbstractThe results of a pilot multimodality program (surgery + radiotherapy + chemotherapy) are reported in 34 women with advanced stage III and IV adenocarcinoma of the breast. The median relapse‐free survival for all patients was 24 months, with 74% of the premenopausal patients and 37% of the postmenopausal alive at five years (P = 0.18). The relapse rate was significantly lower in premenopausal patients when compared to the postmenopausal subgroup. Estrogen receptor status was not predictive for relapse or surviva
点击下载:
PDF
(292KB)
返 回